The year in review: a look at the top developments in real-world evidence and health technology assessment in 2023 

From artificial intelligence (AI)-powered data analysis to regulatory advances, several key developments in 2023 have underscored the pivotal role of real-world evidence (RWE) in paving the way for data-driven, patient-centered health care. New guidance from regulatory and health technology assessment (HTA) bodies, advances in data analytics and technologies and transformative legislation are shaping the way RWE is integrated in drug development, regulatory approvals, and HTA decisions. Here, we look back on some of the key developments from across the globe that took place in 2023. Jump to: Growing emphasis on data quality to support integration into decision-making European developments Updates...